CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Planned sale SVP, Chief Medical Officer sold 8,367 shares at $1.52 ($12,718)
- 4 Open-market sale CEO and President sold 37,733 shares at $1.52 ($57,354)
- 4 Grant or award Chief Commercial Officer acquired 303,300 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 223,950 shares (grant or award)
- 4 Grant or award SVP, Chief Operating Officer acquired 149,300 shares (grant or award)
- 4 Grant or award SVP, CFO and Treasurer acquired 149,300 shares (grant or award)
- 4 Grant or award SVP, Chief Legal Officer acquired 149,300 shares (grant or award)
- 4 Open-market sale CEO and President sold 46,489 shares at $1.68 ($78,102)
- 4 Open-market sale SVP, Chief Medical Officer sold 24,311 shares at $1.68 ($40,842)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP, CFO and Treasurer acquired 370,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
Page 4 of 19 · 378 filings